Showing results (461-470 of 527) with videos related to
Sort By:
Pageof 53
American Journal of Hematology|June 15, 2017
Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and managementMaria Domenica Cappellini, Josep Comin-Colet, Angel de Francisco, et al.Gut|December 17, 2017
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)Silvio Danese, Séverine Vermeire, Paul Hellstern, et al.Journal of Crohn'S & Colitis|July 19, 2015
Cogan's Syndrome in Patients With Inflammatory Bowel Disease--A Case SeriesStephan R Vavricka, Thomas Greuter, Michael Scharl, et al.Nature Medicine|March 9, 2019
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's diseaseBahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, et al.The American Journal of Gastroenterology|January 17, 2018
Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and SymptomsAlain M Schoepfer, Audrey Simko, Christian Bussmann, et al.Plos One|March 22, 2013
Smoking cessation induces profound changes in the composition of the intestinal microbiota in humansLuc Biedermann, Jonas Zeitz, Jessica Mwinyi, et al.The American Journal of Gastroenterology|December 16, 2025
A PROSPECTIVE INTERVENTIONAL STUDY TO EVALUATE THE EFFECT OF HYPOXIA ON HEALTHY VOLUNTEERS AND PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE ALTITUDE IBD STUDYStephan R Vavricka, Jonas Zeitz, Mehdi Madanchi, et al.Molecular Oncology|May 21, 2025
Loss of proton-sensing GPR4 reduces tumor progression in mouse models of colon cancerLeonie Perren, Moana Busch, Pedro A Ruiz, et al.Cellular and Molecular Gastroenterology and Hepatology|November 6, 2025
GPR68, A Proton-sensing GPCR, Mediates Acid-induced Visceral NociceptionLuke W Paine, Rohit Gupta, James P Higham, et al.The American Journal of Gastroenterology|September 16, 2022
Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION TrialSilvio Danese, Marc Ferrante, Brian G Feagan, et al.Pageof 53